Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rastogi, Sanjeev
Affiliations: Department of Kaya Chikitsa, State Ayurvedic College and Department of Holistic Medicine, BMCRC, Vatsala Hospital, Tulsi Das Marg, Lucknow-226004, India. Tel.: +91 94150 22955; E-mail: [email protected]
Abstract: Objective of this study is to identify the attitudes of Ayurvedic physicians about Ayurvedic drug safety in clinical practice. A sample attitude survey among institutionally qualified Ayurvedic physicians from a prespecified part of India through a self administrable questionnaire was adopted as a method to reach at this objective. Survey shows majority of the respondents accepting the potential adversity from Ayurvedic drugs. A substantial number of the respondents have also accepted their ignorance about the idea of pharmacovigilance in Ayurveda. It highlights the need of more guidance about drug safety and usage to Ayurvedic physician to ensure a safe Ayurvedic clinical practice.
Keywords: Attitude, Ayurvedic physician, drug reaction
DOI: 10.3233/JRS-2010-0493
Journal: International Journal of Risk & Safety in Medicine, vol. 22, no. 2, pp. 93-101, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]